Applied Therapeutics (APLT) EBITDA (2018 - 2025)
Applied Therapeutics (APLT) EBITDA from Mar 31, 2018 to Sep 30, 2025. The TTM Applied Therapeutics (APLT) EBITDA is -$18M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Applied Therapeutics (APLT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -90.32% |
| 3 Years TTM | -42.47% |
| 5 Years TTM | -27.07% |
| All Time TTM | -3.53% |
Annual EBITDA change of Applied Therapeutics (APLT)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | -$62M | -41.17% |
| 2024 | -$106M | -11.81% |
| 2023 | -$120M | +45.15% |
| 2022 | -$83M | -21.85% |
| 2021 | -$106M | +12.37% |
| 2020 | -$94M | +106.46% |
| 2019 | -$46M | +175.48% |
| 2018 | -$17M | N/A |
Comparison Applied Therapeutics (APLT) five years EBITDA CAGR with competitors
Applied Therapeutics (APLT) five years EBITDA CAGR is -27.07%.